Intercept-MDS International PhD Fellowships, Marie Skłodowska-Curie Actions (MSCA) Innovative Training Networks, European Commission’s Horizon 2020 Programme

PhD position

About the INTERCEPT-MDS network:

The INTERCEPT-MDS network will train Europe’s first experts in the novel field of disease interception. Through an international call and open recruitment procedure, we will recruit 12 PhD candidates to carry out specific projects under the supervision of a Principal Investigator within one of the 10 world-leading European host institutions from the network.

Our future fellows will be enrolled in a PhD programme and will receive an outstanding and tailored training designed specifically for them. In addition to the training offered by the university, supervisors and host institutions, the PhD candidates will also carry out secondments in other European institutions within the network to provide the needed interactions to achieve research and training excellence, and improve the future career perspectives of our PhD fellows.

The embedding within the INTERCEPT-MDS network’s experts and experienced trainers from two sectors (academia and industry) and two research environments (clinical and basic) offers a unique multidisciplinary and multisectoral training opportunity in the emerging field of disease interception within the health sciences.

Offer Description:

The Innovative Training Network (ITN) “INTERCEPT-MDS - Exploring cell-to-cell heterogeneity and exploiting epigenetic regulation for the interception of myeloid disease cells" is recruiting 12 highly motivated PhD candidates. The offered positions are available with a duration of 36 months. The fellowships are funded as part of the Marie Skłodowska-Curie Actions (MSCA) Innovative Training Networks under the European Commission’s Horizon 2020 programme. MARIE CURIE GRANT AGREEMENT NUMBER: 953407

See more info at: https://ec.europa.eu/research/mariecurieactions/actions/research-networks_en

Host Institutions:

• Josep Carreras Leukaemia Research Institute. Spain > Badalona
• Erasmus Medical Center. The Netherlands > Rotterdam
• Klinikum rechts der Isar der TU München. Germany > Munich
• Institut national de la sante et de la recherche medicale. France > Paris
• Veterinärmedizinische Universität Wien. Austria > Vienna
• Università degli Studi di Firenze. Italy > Florence
• Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus. Germany > Frankfurt
• MLL Munich Leukemia Laboratory. Germany > Munich
• University of Bergen. Norway > Bergen
• BioBam Bioinformatics. Spain > Valencia

For further information on the INTERCEPT-MDS ITN and the application process,
please visit http://intercept-mds.eu/apply-now/.

Applications must contain the following documents (in pdf):

• a CV (including publications, if any),
• a motivation letter,
• 2 reference letters,
• copies of Bachelor's and Master's degree certificates. Candidates should include the transcripts in English of academic records for the studies that make them eligible for a doctoral programme. If these studies have been completed by the deadline for applications, the total number of credits for the degree and the credits awarded must also appear.

Application deadline: 23 Feb 2021

« Back to latest jobs and study opportunities